Evaluating a prognostic tool for metastatic breast cancer care
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
This study is trying to see if a new tool that helps doctors predict outcomes for patients with metastatic breast cancer is easy to use and helpful for improving care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 15 (estimated) |
| Sex | All |
| Sponsor | UNC Lineberger Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Chapel Hill, North Carolina) |
| Trial ID | NCT05440929 on ClinicalTrials.gov |
What this trial studies
This qualitative study involves semi-structured interviews with clinicians who care for patients with metastatic breast cancer to assess the acceptability, appropriateness, and usability of a specific prognostic calculator. The interviews will be conducted until thematic saturation is reached, with an estimated 10 participants. The data collected will be analyzed using themes guided by the Consolidated Framework for Implementation Research (CFIR). The goal is to inform an implementation strategy that enhances the use of this prognostic tool in clinical practice, ultimately aiding oncologists in identifying high-risk patients for better end-of-life care.
Who should consider this trial
Good fit: Ideal candidates for this study are clinicians such as physicians, nurse practitioners, physician assistants, or nurse navigators with at least six months of experience in metastatic breast cancer care.
Not a fit: Patients who do not speak English may not benefit from this study due to language barriers.
Why it matters
Potential benefit: If successful, this study could lead to improved identification of high-risk metastatic breast cancer patients, facilitating better end-of-life care.
How similar studies have performed: While this approach is focused on implementation science, similar studies have shown success in improving clinical tools' usability and acceptance in practice.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Verbal informed consent obtained to participate in the study. 2. Subject is willing and able to comply with study procedures based on the judgement of the investigator or protocol designee. 3. Physician, nurse practitioner, physician assistant, or nurse navigator 4. At least 6 months of experience in the clinical care of patients with metastatic breast cancer in the United States. Exclusion Criteria: * Non-English Speaking
Where this trial is running
Chapel Hill, North Carolina
- University of North Carolina — Chapel Hill, North Carolina, United States (Recruiting)
Study contacts
- Principal investigator: Emily Ray, MD — University of North Carolina, Chapel Hill
- Study coordinator: Terri Eubanks, BSBA
- Email: teubanks@med.unc.edu
- Phone: 919-966-4530
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.